Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells

A. Murumagi, A. Hirasawa, S. Khan, M. Arjama, T. Pellinen, R. Koivisto-Korander, A. Leminen, A. Magi, T. Aittokallio, R. Butzow, O. Kallioniemi

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
JournalInternational Journal of Gynecological Cancer
Pages (from-to)653-653
Number of pages1
Publication statusPublished - Oct 2016
MoE publication typeNot Eligible

Cite this